CN Stock MarketDetailed Quotes

600079 Humanwell Healthcare

Watchlist
  • 23.35
  • -0.03-0.13%
Noon Break Dec 5 11:29 CST
38.11BMarket Cap19.49P/E (TTM)

About Humanwell Healthcare Company

Established in 1993 and listed on the Shanghai Stock Exchange in 1997, it is a leading enterprise in the pharmaceutical industry in Hubei Province, one of the top 30 pharmaceutical industry enterprises in China, a national scientific and technological innovation demonstration enterprise, and a leading enterprise in the internationalization of Chinese pharmaceutical preparations. It has established a leading or leading position in various domestic segments such as narcotic drugs, steroidal hormone drugs, and Uyghur folk medicine. It is mainly engaged in R&D, production and sales of pharmaceuticals, and is a leading enterprise in the pharmaceutical industry in Hubei Province and a national technological innovation demonstration enterprise. The main products include fentanyl citrate injections, sufentanyl citrate injections, remifentanil hydrochloride injections, hydromorphone hydrochloride injections, nalbuphine hydrochloride injections, etc. Corporate honors: The company has been selected by the Ministry of Industry and Information Technology's “China's Top 100 Pharmaceutical Industry List” for 13 consecutive years, and selected as the “2022 China Top 500 Manufacturing Enterprises”.

Company Profile

Short Name-A人福医药
Symbol-A600079
Company NameHumanwell Healthcare (Group) Co.,Ltd.
Listing DateJun 6, 1997
Issue Price5.22
Shares Offered20.00M share(s)
FoundedMar 30, 1993
Listed ExchangeSH Stock Exchange
Legal Representativejie li
General Managerxiafei deng
Secretaryqianlun li
Accounting FirmDaxin Certified Public Accountants (Special General Partnership)
Securities Representativewenjing wu
Legal CounselHubei Shanhe Law Firm
Employees558
Phone027-87597232
Office AddressNo. 666 Gaoxin Avenue, Donghu High-tech Zone, Wuhan
Zip Code430075
Registered AddressNo. 666 Gaoxin Avenue, Donghu High-tech Zone, Wuhan, Hubei
Fax027-87596393
Emailrenfu.pr@renfu.com.cn
Business License420100000011675
BusinessPharmaceutical research and development; biotechnology research and development; R&D and sales of chemical products (except dangerous chemicals); technology development, technology transfer and technical services; import and export of goods, technology import/export, agent import and export (excluding goods or technology prohibited or restricted by the country); investment in the pharmaceutical industry and medical institutions; management of the pharmaceutical industry and medical institutions; Internet pharmaceutical/medical device information services; organization of “three to one supplement” business. (Projects with special requirements in countries within the scope mentioned above are operated within the approved period after approval or with a license).

Company Executives

  • Name
  • Position
  • Salary
  • jie li
  • Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee
  • 5.67M
  • hansheng zhou
  • Directors, Strategy Committee Member, Audit Committee Member
  • 1.81M
  • xiaodong zhang
  • Directors, Strategy Committee Member
  • 1.81M
  • xuehai wang
  • Directors
  • 618.50K
  • xiafei deng
  • Directors, President, Strategy Committee Member
  • 7.19M
  • linqing liu
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • 100.00K
  • rui zhou
  • Independent Directors
  • 100.00K
  • suhua zhang
  • Independent Directors
  • 100.00K
  • qianlun li
  • Board Secretary, VP
  • 1.97M
  • wenjing wu
  • Securities Affairs Representative
  • --
  • yuexin du
  • Chief Supervisor, Auditors
  • 100.00K
  • chenggang zheng
  • Auditors
  • 841.70K
  • min qi
  • Auditors
  • 100.00K
  • qun yu
  • VP
  • 3.69M
  • yajun wu
  • VP, Chief Financial Officer
  • 2.08M
  • qiang yin
  • VP
  • 1.97M
  • hongjie zhang
  • VP
  • 4.97M
  • lie li
  • VP
  • 3.70M
  • wentao du
  • VP
  • 4.07M
  • yuan xia
  • Employee Supervisors
  • 912.80K
  • na kong
  • Employee Supervisors
  • 1.82M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data